Camillo Porta. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Combined Chemotherapy Protocols/therapeutic useCarcinoma, Renal Cell/drug therapyDrug Resistance, NeoplasmFemaleHumansKidney Neoplasms/drug therapyMaleMolecular Targeted TherapyProtein Kinase Inhibitors/administration & dosageReceptor Protein-Tyrosine Kinases/antagonists & inhibitors
Substances: See more » Protein Kinase InhibitorsReceptor Protein-Tyrosine Kinases
Year: 2011 PMID: 21820238 DOI: 10.1016/j.eururo.2011.07.058
Source DB: PubMed Journal: Eur Urol ISSN: 0302-2838 Impact factor: 20.096